Global Dry Eye Syndrome Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

MarketResearch.biz delivers in-depth insights on the global dry eye syndrome treatment market in its upcoming report titled, “Global Dry Eye Syndrome Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027”. The global dry eye syndrome treatment market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global dry eye syndrome treatment market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global dry eye syndrome treatment market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global dry eye syndrome treatment market report has been segmented on the basis of type, product type, distribution channel, and region.

Request Covid - 19 Impact

Dry eye syndrome also known as keratoconjunctivitis sicca (KCS) is a condition when an individual suffers from dry eyes. The symptoms of dry eye syndrome include irritation, redness, discharge, blurred vision, and easily fatigued eyes. In severe cases, scarring of the cornea may occur if not treated properly. Dry eye syndrome is one of most common eye disorder which is particularly common in geriatric population. Most cases of dry eye syndrome can be treated with a combination of artificial tears, steroid eye drops, warm compressors. Regular usage of contact lenses also increases risk of dry eye syndrome in the individuals.

Increasing awareness about the diagnosis and treatment of the dry eye syndrome is a key factor driving growth of the global dry eye syndrome treatment market. In addition, high prevalence of other condition such as diabetes can affect functioning of eyes, and rising geriatic population are other factor expected to fuel growth to the global dry eye syndrome treatment market over the forecast period. Furthermore, advancements in healthcare sectors, and governments initiatives to support medical research are other factors anticipated to boost growth of the global dry eye syndrome treatment market over the forecast period.

However, popularity of self-medication by patients is a key factor restraining growth of the global dry eye syndrome treatment market. Additionally, treatment of dry eye syndrome does not offer permanent cure, and expiration of patents due to drugs used in the treatment of dry eye syndrome treatment are other factors expected to hamper growth of the global dry eye syndrome treatment market over the forecast period.

North America is a dominant player in the global dry eye syndrome treatment market and accounts for highest market share in terms of revenue as compared to that of markets in other regions. This can be attributed to rising geriatric population and rising awareness among general population about treatment of dry eye syndrome in the region. The market in Europe accounts for second-highest revenue share contribution to the dry eye syndrome treatment market followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. The market in Asia Pacific is to register highest CAGR in terms of revenue, owing to advancements in healthcare sector and government initiatives in this region.

Global dry eye syndrome treatment market segmentation by of type:

• Aqueous dry eye syndrome
• Evaporative dry eye syndrome

Global dry eye syndrome treatment market segmentation by product type

• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment

Global market segmentation on the basis of distribution channel:

• Hospitals
• Eye Health Clinics
• Retail Pharmacies
• Online Pharmacies

Global market segmentation on the basis of region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Novartis AG
• Allergan, Plc
• Alcon, Inc.
• Otsuka Holdings
• Can Fite Biopharma
• Shire Plc.
• Valeant Pharmaceuticals International, Inc.
• Akorn, Inc.
• Abbott Laboratories
• Auven Therapeutics Management L.L.L.P